A 48-year-old man has biopsy-proven Helicobacter pylori-positive duodenal ulcer disease. He has no significant comorbidities and no recent macrolide exposure. According to current Australian practice aligned with Therapeutic Guidelines and RACGP updates, what is the MOST appropriate first-line eradication regimen?